instead, it disproportionately increases luminal exposure, leading to class-related gastrointestinal effects, unpredictable safety profiles, and economic infeasibility before therapeutic efficacy can be achieved (Figure 2)
It was launched in February 2024 and clinical trials have suggested better long-term weight-loss results than both Wegovy and Ozempic
For those seeking comprehensive support for their weight management journey, understanding all factors, including effective dosing, is essential
Conclusion Wegovy and Mounjaro are both genuinely effective weight loss injections that work, are approved, and are helping thousands of people across the UK
EBioMedicine 55 , 102766 (2020)
This positive pressure technique makes drawing easier and more accurate